| [1] Weller PF, Bubley GJ.The idiopathic hypereosinophilic syndrome[J].Blood,1994,83(10): 2759-2779.[2] 宋 琳,韩锋锋,黄雁西,等.以肾病综合征为首发表现的特发性嗜酸粒细胞增多综合征诊治反思并文献复习[J].临床误诊误治杂志,2014,27(2): 52-55.[3] Simon HU,Rothenberg ME,Bochner BS,et al.Refining the definition of hypereosinophilic syndrome[J]. J Allergy Clin Immunol,2010, 126(1): 45-49.[4] Hardy WR,Anderson RE.The hypereosinophilic syndromes[J].Ann Intern Med,1968,68(6):1220-1229.[5] Rothenberg ME,Klion AD,Roufosse FE,et al.Treatment of patients with the hypereosinophilic syndrome with mepolizumab[J]. N Engl J Med, 2008,358(12):1215-1228.[6] Crane MM,Chang CM,Kobayashi MG,et al.Incidence of myeloproliferative hypereosinophilic syndrome in the Unites States and an estimate of all hypereosinophilic syndrome incidence[J].J Allergy Clin Immunol,2010,126(1):179-181.[7] van Grotel M,de Hoog M,de Krijger RR,et al.Hypereosinophilic syndrome in children[J].Leuk Res,2012,36(10):1249-1254.[8] Kim KM, Bae MH.Cause and incidence of eosinophilia in children: a single center study in one year[J]. Allergy Asthma Respir Dis,2014,2(5):358-361.[9] Butterfield JH,Gleich GJ.Response of six patients with idiopathic hypereosinophilic syndromee to interferon alpha[J]. J Allergy Clin Immunol,1994,94(6 Pt 2):1318-1326.[10] Ogbogu PU,Bochner BS,Butterfield JH,et al.Hypereosinophilic syndromes: A multicenter, retrospective analysis of clinical characteristics and response to therapy[J]. J Allergy Clin Immunol,2009,124(6):1319-1325.[11] Jeon YW, Hong SJ, Kim HJ,et al.A hypereosinophilic syndrome presenting as eosinophilic colitis[J].Clin Endosc,2012,45(4): 444-447.[12] Bakhshi S, Hamre M, Mohamed AM, et al. t(5;9)(q11;q34): A novel familial translocation involving Abelson oncogene and association with hypereosinophilia[J]. J Pediatr Hematol Oncol,2003,25(1):82-84.[13] Cogan E, Roufosse F.Clinical management of the hypereosinophilic syndromes[J]. Expert Rev Hematol,2012,5(3):275-289.[14] Talley NJ,Shorter RG,Philips SF,et al.Eosinophilic gastroenteritis: a clinicopathological study of patients with diseases of the mucosa, muscle layer, and subserosal tissues [J]. Gut,1990,31(1):54-58.[15] Yilmaz I, Kaynar L, Tutar N,et al. Response to imatinib in patient with corticosteroid-unresponsive idiopathic hypereosinophilic syndrome[J].Rev Port Pneumol(2006),2016,22(1):59-60.[16] Gotlib J. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management [J]. Am J Hematol, 2015,90(11):1077-1089.[17] Helbig G, Soja A, Swiderska A, et al.Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript [J].Leuk Lymphoma,2016,57(3):708-710.[18] Cools J, De Angelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J].N Engl J Med,2003,348(13):1201-1214.[19] Guo ZP, Yang LH, Chen JF, et al. Response to corticosteroids and cytotoxic drugs in a case of idiopathic hypereosinophilic syndrome with predominantly elevated eosinophils and multiple clinical manifestations [J].Indian J Hematol Blood Transfus,2014,30 (Suppl 1): 162-165.[20] 王 妍,王心怡,李 丹,等.以肝占位病变为首发表现的嗜酸粒细胞增多综合征1例报告[J].中国实用内科杂志,2015,35(12):1055-1057.[21] 陈 碧,蒋捍东.伴肺部阴影的嗜酸粒细胞增多症[J].中国实用内科杂志,2014,34(8):740-743. |
